The Health Resources and Services Administration has issued a long-awaited proposed rule updating the 340B administrative dispute resolution (ADR) process.
The calendar year 2023 Outpatient Prospective Payment System (OPPS) final rule, issued Nov. 1, 2022, by the Centers for Medicare and Medicaid Services estimates that Medicare expenditures under OPPS will increase by $6.5 billion, relative to estimated current year payments, based on changes in the final rule. Key provisions are:
On Sept. 28, a federal district court ruled that the Department of Health & Human Services (HHS) must immediately halt the department’s cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that participate in the 340B Drug Pricing Program. HHS will begin restoring a payment rate of average sales price plus […]
CHA submitted comments on the calendar year (CY) 2023 outpatient prospective payment system (OPPS) proposed rule. In the letter, CHA raises concerns about the inadequate proposed market basket update and asks CMS to use alternative sources of data that better reflect input price inflation experienced by providers to calculate the CY 2023 market basket update. […]
CHA has issued a comprehensive summary of the calendar year (CY) 2023 outpatient prospective payment system (OPPS) proposed rule.
On June 15, the U.S. Supreme Court ruled in favor of the American Hospital Association (AHA) in its lawsuit against the federal Department of Health & Human Services (HHS) challenging HHS’ reduction of prescription drug reimbursement rates for 340B hospitals for 2018 and 2019.
The Health Resources and Services Administration (HRSA) announced the implementation of Section 121 of the Consolidated Appropriations Act of 2022, which creates an eligibility exception that permits certain hospitals’ reinstatement into the 340B Drug Pricing Program if they meet certain qualifications.
On Nov. 2, the Centers for Medicare & Medicaid Services (CMS) finalized Medicare payment rates for hospital outpatient and ambulatory surgical center (ASC) services. CMS estimates that Medicare expenditures under the outpatient prospective payment system (OPPS) will increase by $1.3 billion based on changes in the final rule.
CHA has issued a detailed summary of the federal fiscal year (FFY) 2022 inpatient prospective payment system (IPPS) final rule. The policy and payment provisions in the final rule are effective for FFY 2022 discharges, beginning Oct. 1.
CHA has submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the calendar year 2022 outpatient prospective payment system (OPPS) proposed rule.